SILVER SPRING, Md. (Nov. 19, 2025) Martha Sedegah, Naval Medical Research Command’s (NMRC) director of Clinical Immunology and Parasitology, Agile Vaccines and Therapeutics (AVAT) Department, speaks about the research on malaria vaccine development being conducted in the AVAT laboratory. Malaria is a major threat to deployed warfighter health and readiness that can result in time lost from work, as well as the risk of developing secondary illnesses. NMRC, headquarters of Navy Medicine Research & Development, is engaged in a broad spectrum of activity from basic science in the laboratory to field studies in austere and remote areas of the world to investigations in operational environments. In support of Navy, Marine Corps and joint U.S. warfighter health, readiness and lethality, researchers study infectious diseases, biological warfare detection and defense, combat casualty care, environmental health concerns, aerospace and undersea medicine, operational mission support and epidemiology. (U.S. Navy photo by Aleece Williams/Released)
| Date Taken: | 11.19.2025 |
| Date Posted: | 11.20.2025 13:46 |
| Photo ID: | 9400493 |
| VIRIN: | 251119-N-AJ766-1018 |
| Resolution: | 5211x3474 |
| Size: | 1.45 MB |
| Location: | SILVER SPRING, MARYLAND, US |
| Web Views: | 7 |
| Downloads: | 0 |
This work, NMRC Researchers Submit Provisional Patent for Nanoparticle Vaccine [Image 7 of 7], by Aleece Williams, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
NMRC Researchers Submit Provisional Patent for Nanoparticle Vaccine
No keywords found.
